Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Roche Holding AG Basel American Depositary Shares (OP:RHHBY)

50.40 UNCHANGED

Streaming Delayed Price Updated: 3:59 PM EDT, Apr 1, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	9,398
Open	50.40
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	50.40
Today's Range	50.40 - 50.40
52wk Range	34.75 - 60.85
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Biogen Acquires Apellis Pharmaceuticals in $5.6 Billion Deal After Clinical Success

April 01, 2026

In a move that has sent shockwaves through the biotechnology sector, Apellis Pharmaceuticals (Nasdaq: APLS) witnessed an extraordinary 135.7% surge in its share price on March 31, 2026. The massive...

Via MarketMinute

United Therapeutics Surges 14% on Groundbreaking Tyvaso Phase 3 Results for IPF

March 31, 2026

In a landmark moment for respiratory medicine and biotechnology, United Therapeutics (NASDAQ:UTHR) announced late Monday, March 30, 2026, that its pivotal TETON-1 Phase 3 study for nebulized Tyvaso...

Via MarketMinute

Performance

YTD	-2.0%	-2.0%
1 Month	-12.9%	-12.9%
3 Month	-2.3%	-2.3%
6 Month	+12.4%	+12.4%
1 Year	+22.7%	+22.7%

More News

The $1 Trillion Goliath: Why Eli Lilly’s $6.3B Centessa Bet Defines the Future of Neuroscience

March 31, 2026

Via Finterra

AstraZeneca (AZN) Shares Rally After Breakthrough Chronic Lung Disease Trial Results

March 27, 2026

Via MarketMinute

Kodiak Sciences Surges 19% as Phase 3 GLOW2 Trial Delivers Vital Win for Diabetic Retinopathy Treatment

March 26, 2026

Via MarketMinute

Sarepta Therapeutics (SRPT) Stock Surges 34.98% on Breakthrough Clinical Data

March 26, 2026

Via MarketMinute

Merck & Co. (MRK) 2026 Analysis: Navigating the Keytruda Cliff with Pipeline-Driven Resilience

March 25, 2026

Via Finterra

Retirees: Collect a High Dividend While Diversifying Your Portfolio With This ETF ↗

March 24, 2026

Via The Motley Fool

Abbott Laboratories Finalizes $21 Billion Acquisition of Exact Sciences, Redefining the Future of Cancer Diagnostics

March 23, 2026

Via MarketMinute

The Best Healthcare Stocks to Buy With $50 Right Now ↗

March 18, 2026

Via The Motley Fool

Is Eli Lilly's Weight Loss Empire in Trouble? ↗

March 13, 2026

Via The Motley Fool

3 ETFs to Avoid as Oil Shock Hits Markets ↗

March 12, 2026

Via MarketBeat

Genentech Provides Update on Phase III persevERA Study in ER-positive Advanced Breast Cancer

March 09, 2026

From Genentech

Via Business Wire

2 Underrated Weight Loss Stocks to Buy Now ↗

March 08, 2026

Via The Motley Fool

New England Journal of Medicine Publishes Phase III ALLEGORY Data Showing Genentech’s Gazyva Significantly Reduces Disease Activity in the Most Common Form of Lupus

March 06, 2026

From Genentech

Via Business Wire

Genentech Announces Positive Phase II Results for Petrelintide, an Amylin Analog Developed for People Living With Overweight and Obesity

March 05, 2026

From Genentech

Via Business Wire

Genentech's Fenebrutinib Confirms Its Potential as First and Only BTK Inhibitor for Relapsing and Primary Progressive MS in Third Positive Phase III Study (FENhance 1)

March 02, 2026

From Genentech

Via Business Wire

The Lilly Era: How Eli Lilly Transformed into a Trillion-Dollar Healthcare Titan

February 27, 2026

Via MarketMinute

Pfizer Secures Full FDA Approval for BRAFTOVI in First-Line Colorectal Cancer, Bolstering Oncology Growth Strategy

February 26, 2026

Via MarketMinute

Worried About Tariffs? Buy 2 Vanguard Index Funds That Are Beating the S&P 500 in 2026. ↗

February 26, 2026

Via The Motley Fool

FDA Approves Genentech’s Venclexta® Plus Acalabrutinib Combination Regimen for Previously Untreated Chronic Lymphocytic Leukemia

February 20, 2026

From Genentech

Via Business Wire

FDA Accepts New Drug Application for Genentech’s Giredestrant in ESR1-Mutated, ER-Positive Advanced Breast Cancer

February 20, 2026

From Genentech

Via Business Wire

Pfizer’s BRAFTOVI BREAKWATER Trial Delivers Landmark Survival Gains in Colorectal Cancer

February 19, 2026

Via MarketMinute

Retina’s ‘Sustained’ Moment: Ocular Therapeutix Braces for Game-Changing Phase 3 AXPAXLI Data

February 16, 2026

Via MarketMinute

Buy 2 Vanguard Index Funds to Beat the S&P 500 in the Next Decade, According to Wall Street Analysts ↗

February 16, 2026

Via The Motley Fool

Frequently Asked Questions

Is Roche Holding AG Basel American Depositary Shares publicly traded?

Yes, Roche Holding AG Basel American Depositary Shares is publicly traded.

What exchange does Roche Holding AG Basel American Depositary Shares trade on?

Roche Holding AG Basel American Depositary Shares trades on the OTC Traded

What is the ticker symbol for Roche Holding AG Basel American Depositary Shares?

The ticker symbol for Roche Holding AG Basel American Depositary Shares is RHHBY on the OTC Traded

What is the current price of Roche Holding AG Basel American Depositary Shares?

The current price of Roche Holding AG Basel American Depositary Shares is 50.40

When was Roche Holding AG Basel American Depositary Shares last traded?

The last trade of Roche Holding AG Basel American Depositary Shares was at 04/01/26 03:59 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.